KLOW is the most comprehensive repair blend: 4 peptides covering matrix, vascular, migration, and anti-inflammatory axes. KPV's NF-κB inhibition adds inflammation resolution absent from other repair formulations.
KLOW Blend is the most comprehensive multi-peptide repair research formulation available, uniquely combining tissue repair peptides with an anti-inflammatory component. GHK-Cu (50mg) provides ECM remodeling and antioxidant defense. TB-500 (10mg) drives cell migration and anti-fibrotic Ac-SDKP signaling. BPC-157 (10mg) modulates VEGF and NO for vascular support. KPV (10mg) — the differentiating component — adds potent NF-κB pathway inhibition and pro-inflammatory cytokine suppression (IL-1β, IL-6, TNF-α).
The inclusion of KPV addresses a fundamental principle of tissue repair biology: inflammation must be resolved for regeneration to proceed. Persistent inflammation drives fibrosis rather than functional tissue restoration. By incorporating KPV’s receptor-independent NF-κB inhibition alongside three repair peptides, KLOW enables research into the critical inflammation-to-resolution transition during tissue healing. Total content: 80mg per vial.
Co-lyophilized with ≥99% purity per component. Store at -20°C desiccated. For regenerative and anti-inflammatory research only.